|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
Chest, Vol 102, 725-731, Copyright © 1992 by American College of Chest Physicians
ARTICLES |
M Lahav, A Regev, P Ra'anani and E Theodor
Department of Internal Medicine E, Beilinson Medical Center, Petah Tiqva, Israel.
Several reports have suggested that continuous intravenous administration of loop diuretics may be superior to intermittent administration. We performed a prospective randomized crossover study comparing intermittent intravenous administration (IA) of furosemide with continuous infusion following a single loading dose (LDCI) in nine patients with severe congestive heart failure. At the time of hospital admission, patients were randomly assigned to one of two treatment groups. One group (four patients) received an IV bolus injection of furosemide followed immediately by a continuous infusion for 48 h. The second group (five patients) was treated with three IV bolus injections a day for 48 h. Total doses of furosemide were equivalent in the two groups. After 48 h, each patient was crossed over to the other method and treated for an additional 48 h. LDCI produced significantly greater diuresis and natriuresis than IA (total urine output increased by 12 to 26 percent, total sodium excretion increased by 11 to 33 percent) (p less than 0.01). There were no significant differences in side effects between the two methods. These results indicate that LDCI may be a preferred method for administration of furosemide in patients with congestive heart failure.
This article has been cited by other articles:
![]() |
B. E Gulbis and A. P Spencer Efficacy and Safety of a Furosemide Continuous Infusion Following Cardiac Surgery Ann. Pharmacother., October 1, 2006; 40(10): 1797 - 1803. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Davis, N. M. Albert, and J. B. Young Palliation of heart failure American Journal of Hospice and Palliative Medicine, May 1, 2005; 22(3): 211 - 222. [Abstract] [PDF] |
||||
![]() |
Endorsed by the European Society of Intensive Care, Authors/Task Force Members, M. S. Nieminen, M. Bohm, M. R. Cowie, H. Drexler, G. S. Filippatos, G. Jondeau, Y. Hasin, J. Lopez-Sendon, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology Eur. Heart J., February 2, 2005; 26(4): 384 - 416. [Full Text] [PDF] |
||||
![]() |
S U Shah, S Anjum, and W A Littler Use of diuretics in cardiovascular diseases: (1) heart failure Postgrad. Med. J., April 1, 2004; 80(942): 201 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
L K M De Bruyne Mechanisms and management of diuretic resistance in congestive heart failure Postgrad. Med. J., May 1, 2003; 79(931): 268 - 271. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Shankar and D. C. Brater Loop diuretics: from the Na-K-2Cl transporter to clinical use Am J Physiol Renal Physiol, January 1, 2003; 284(1): F11 - F21. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |